Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 076732
Company: SANDOZ
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
METOLAZONE METOLAZONE 2.5MG TABLET;ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
12/19/2003 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
03/10/2011 SUPPL-7 Labeling-Package Insert

Label is not available on this site.

METOLAZONE

TABLET;ORAL; 2.5MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
METOLAZONE METOLAZONE 2.5MG TABLET;ORAL Prescription No AB 213251 ALEMBIC PHARMS LTD
METOLAZONE METOLAZONE 2.5MG TABLET;ORAL Prescription No AB 214799 BAYSHORE PHARMS LLC
METOLAZONE METOLAZONE 2.5MG TABLET;ORAL Prescription No AB 213827 INNOGENIX
METOLAZONE METOLAZONE 2.5MG TABLET;ORAL Prescription No AB 076698 MYLAN
METOLAZONE METOLAZONE 2.5MG TABLET;ORAL Prescription No AB 076732 SANDOZ
ZAROXOLYN METOLAZONE 2.5MG TABLET;ORAL Prescription Yes AB 017386 LANNETT CO INC

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English